SCHEMBL8416487

SCHEMBL8416487

Clc1cnn(CCCCN2CCN(c3ccccc3)CC2)c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.60
DRD4 P21917 4/20 0.59
HTR2C P28335 4/20 0.59
SIGMAR1 Q99720 3/20 0.54
DRD2 P14416 2/20 0.53
HTR2A P28223 2/20 0.53
HRH1 P35367 2/20 0.53
LMNA P02545 1/20 0.53
PKM P14618 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CYP2D6 P10635 1/20 0.52
HTR1A P08908 4/20 0.52
ADRA1D P25100 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8419627 0.88 KCNH2 (0.71) KCNH2DRD4SIGMAR1DRD2HTR2A
SCHEMBL8416467 0.85 KDM4E (0.59) DRD4DRD2HTR2ALMNAHTR1A
SCHEMBL8416326 0.84 HSD17B10 (0.57) KCNH2DRD4DRD2HTR2ALMNA
SCHEMBL8417636 0.83 KCNH2 (0.69) KCNH2DRD4SIGMAR1DRD2HTR2A
SCHEMBL8416458 0.82 SIGMAR1 (0.59) KCNH2SIGMAR1DRD2HTR2AHTR1A
SCHEMBL8416478 0.82 DRD2 (0.56) DRD4SIGMAR1DRD2HTR2AHRH1
Lesopitron SCHEMBL246589 0.81 HTR1A (0.52) DRD4DRD2HTR2ACYP2D6HTR1A
SCHEMBL9699873 0.81 DRD3 (0.58) KCNH2DRD4DRD2HTR2AHRH1
SCHEMBL8416451 0.80 HTR1A (0.56) DRD4DRD2HTR2ALMNAHTR1A
Lesopitron SCHEMBL9201343 0.80 HTR1A (0.51) DRD2HTR2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP disclosed
US-5382586-A Tranquilizers LABORATORIOS DEL DR. ESTEVE S.A. (ES) 1995-01-17 US disclosed
US-5292739-A Aryl(or heteroaryl) piperazinylalkylazole derivatives, their preparation and their application as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1994-03-08 US disclosed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP disclosed